Troschke-Meurer, S.; Zumpe, M.; Ahrenberg, P.M.; Ebeling, T.; Siebert, N.; Grabarczyk, P.; Lode, H.N.
Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition. Cancers 2025, 17, 2510.
https://doi.org/10.3390/cancers17152510
AMA Style
Troschke-Meurer S, Zumpe M, Ahrenberg PM, Ebeling T, Siebert N, Grabarczyk P, Lode HN.
Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition. Cancers. 2025; 17(15):2510.
https://doi.org/10.3390/cancers17152510
Chicago/Turabian Style
Troschke-Meurer, Sascha, Maxi Zumpe, Peter Moritz Ahrenberg, Torsten Ebeling, Nikolai Siebert, Piotr Grabarczyk, and Holger N. Lode.
2025. "Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition" Cancers 17, no. 15: 2510.
https://doi.org/10.3390/cancers17152510
APA Style
Troschke-Meurer, S., Zumpe, M., Ahrenberg, P. M., Ebeling, T., Siebert, N., Grabarczyk, P., & Lode, H. N.
(2025). Affinity Affects the Functional Potency of Anti-GD2 Antibodies by Target-Mediated Drug Disposition. Cancers, 17(15), 2510.
https://doi.org/10.3390/cancers17152510